Kathleen Rickard
2022
In 2022, Kathleen Rickard earned a total compensation of $1.5M as Chief Medical Officer at Verona Pharma plc, a 170% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $217,220 |
|---|---|
| Salary | $434,439 |
| Stock Awards | $863,000 |
| Other | $3,342 |
| Total | $1,518,001 |
Rickard received $863K in stock awards, accounting for 57% of the total pay in 2022.
Rickard also received $217.2K in non-equity incentive plan, $434.4K in salary and $3.3K in other compensation.
Rankings
In 2022, Kathleen Rickard's compensation ranked 2,200th out of 5,683 executives tracked by ExecPay. In other words, Rickard earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,200 out of 5,683 | 61st |
Division Manufacturing | 1,185 out of 3,091 | 62nd |
Major group Chemicals And Allied Products | 510 out of 1,406 | 64th |
Industry group Drugs | 470 out of 1,307 | 64th |
Industry Pharmaceutical Preparations | 341 out of 949 | 64th |
Source: SEC filing on March 21, 2023.
Rickard's colleagues
We found two more compensation records of executives who worked with Kathleen Rickard at Verona Pharma plc in 2022.